References
- Urru SAM, Maines E, Campomori A, Soffiati M. Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance. Hum Vaccin Immunother. 2021:1-3. doi:10.1080/21645515.2021.1943992.
- European Medicines Agency. First COVID-19 vaccine approved for children aged 12 to 15 in EU. News May 28, 2021. https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu.
- Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic. May, 2021. https//www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use
- European Medicines Agency. EMA evaluating the use of COVID-19 Vaccine Moderna in young people aged 12 to 17. News, June 06, 2021. https://www.ema.europa.eu/en/news/ema-evaluating-use-covid-19-vaccine-moderna-young-people-aged-12-17
- Garrido C, Curtis AD, Dennis M, Pathak SH, Gao H, Montefiori D, Tomai M, Fox CB, Kozlowski PA, Scobey T, et al. Sars Cov 2 vaccines elicit durable immune responses in infant Rhesus macaques. Sci Immunol. 2021 15;6(60):eabj3684. doi:10.1126/sciimmunol.abj3684
- Gallo G, Mel R, Ros E, Filia A. Guida alle controindicazioni alle vaccinazioni (aggiornamento 2018). Roma (Italy): Istituto Superiore di Sanità; 2019. (Rapporti ISTISAN 19/3).